Cellectar Biosciences Inc (CLRB)
2.04
+0.01
(+0.49%)
USD |
NASDAQ |
Nov 05, 16:00
2.04
0.00 (0.00%)
After-Hours: 18:32
Cellectar Biosciences Total Liabilities (Quarterly): 17.00M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.00M |
| March 31, 2024 | 16.74M |
| December 31, 2023 | 27.23M |
| September 30, 2023 | 34.90M |
| June 30, 2023 | 6.976M |
| March 31, 2023 | 7.504M |
| December 31, 2022 | 13.44M |
| September 30, 2022 | 6.569M |
| June 30, 2022 | 5.698M |
| March 31, 2022 | 4.781M |
| December 31, 2021 | 4.157M |
| September 30, 2021 | 3.368M |
| June 30, 2021 | 3.755M |
| March 31, 2021 | 5.289M |
| December 31, 2020 | 3.865M |
| September 30, 2020 | 4.473M |
| June 30, 2020 | 3.867M |
| March 31, 2020 | 3.444M |
| December 31, 2019 | 3.191M |
| September 30, 2019 | 3.428M |
| June 30, 2019 | 3.150M |
| March 31, 2019 | 2.702M |
| December 31, 2018 | 1.793M |
| September 30, 2018 | 2.661M |
| June 30, 2018 | 2.290M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.109M |
| December 31, 2017 | 2.117M |
| September 30, 2017 | 2.279M |
| June 30, 2017 | 1.737M |
| March 31, 2017 | 1.548M |
| December 31, 2016 | 1.785M |
| September 30, 2016 | 1.579M |
| June 30, 2016 | 1.549M |
| March 31, 2016 | 2.993M |
| December 31, 2015 | 5.947M |
| September 30, 2015 | 5.781M |
| June 30, 2015 | 6.207M |
| March 31, 2015 | 6.323M |
| December 31, 2014 | 6.722M |
| September 30, 2014 | 2.570M |
| June 30, 2014 | 8.429M |
| March 31, 2014 | 8.767M |
| December 31, 2013 | 5.116M |
| September 30, 2013 | 5.221M |
| June 30, 2013 | 6.681M |
| March 31, 2013 | 7.181M |
| December 31, 2012 | 1.320M |
| September 30, 2012 | 1.322M |
| June 30, 2012 | 1.219M |
| March 31, 2012 | 1.087M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.191M
Minimum
Dec 2019
34.90M
Maximum
Sep 2023
9.277M
Average
5.289M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 44.92M |
| Actinium Pharmaceuticals Inc | 46.03M |
| Chimerix Inc | 22.93M |
| Marinus Pharmaceuticals Inc | 134.43M |
| Jaguar Health Inc | 44.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.38M |
| Shareholders Equity (Quarterly) | 12.38M |